ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews ...

Partnership will integrate ICON's clinical trial technology with Advarra's purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership ...